BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11745423)

  • 1. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
    Goto H; Osaki T; Kijima T; Nishino K; Kumagai T; Funakoshi T; Kimura H; Takeda Y; Yoneda T; Tachibana I; Hayashi S
    Int J Cancer; 2001 Nov; 94(3):414-9. PubMed ID: 11745423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
    Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
    Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Yamaue H; Tanimura H
    Oncology; 2000 Sep; 59(3):255-65. PubMed ID: 11053994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
    Ohashi M; Kanai F; Tanaka T; Lan KH; Shiratori Y; Komatsu Y; Kawabe T; Yoshida H; Hamada H; Omata M
    Jpn J Cancer Res; 1998 Apr; 89(4):457-62. PubMed ID: 9617353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells.
    Okabe S; Arai T; Yamashita H; Sugihara K
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):367-73. PubMed ID: 12783317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX; Bian HB; Yang JS; De W; Ji XH
    Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gene therapy using prostate-specific membrane antigen promoter/enhancer with Cre Recombinase/LoxP system for prostate cancer cells under androgen ablation condition.
    Ikegami S; Tadakuma T; Suzuki S; Yoshimura I; Asano T; Hayakawa M
    Jpn J Cancer Res; 2002 Oct; 93(10):1154-63. PubMed ID: 12417046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif.
    Nishino K; Osaki T; Kumagai T; Kijima T; Tachibana I; Goto H; Arai T; Kimura H; Funakoshi T; Takeda Y; Tanio Y; Hayashi S
    Int J Cancer; 2001 Mar; 91(6):851-6. PubMed ID: 11275991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
    Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
    Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.
    Wang HW; Breslin MB; Chen C; Akerstrom V; Zhong Q; Lan MS
    Hum Gene Ther; 2009 Nov; 20(11):1308-18. PubMed ID: 19604042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
    Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
    BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K; Löser P; Arnold W; Bartels T; Strauss M
    Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.
    Osaki T; Tanio Y; Tachibana I; Hosoe S; Kumagai T; Kawase I; Oikawa S; Kishimoto T
    Cancer Res; 1994 Oct; 54(20):5258-61. PubMed ID: 7923150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
    Wildner O; Blaese RM; Morris JC
    Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.
    Li BJ; Zhang C; Yi YX; Hao Y; Liu XP; Ou QJ
    World J Gastroenterol; 2007 Aug; 13(29):4006-10. PubMed ID: 17663519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
    Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.